WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Regulatory Guidance forDeveloping Technologies.

Our attorneys bring deep healthcare and FDA regulatory knowledge to the questions that arise as technology reshapes how care is delivered, how health data moves, and how products reach the market.

The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.

For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.

Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.

Read More About Us
Quick Links
  • Visit our Careers Microsite
  • Find the right attorney
  • Sign in to Neuron

Wilson Sonsini secured a jury trial win for Google in a case alleging misuse of advertising technology.

Click for additional details.
Careers

We look for the best and brightest of tomorrow and develop careers from the ground up.

  • Attorney Recruiting
  • Professional Staff
  • Contacts

News and Featured Insights

Alerts
FINRA Adopts New Intraday Margin Requirements
White Papers/Briefs
Focused on Fairness: How the FTC’s Contact Lens Rule Delivers Choice, Competition, and Savings to Consumers
Newsletters
The Entrepreneurs Report – Q2 2026
Leading Matters
Client Highlights
Wilson Sonsini Advises Profound on $180 Million Series D at $1.8 Billion Valuation
On September 15, 2026, Profound, a marketing platform for the AI era, announced it raised a $180 million Series D at a $1.8 billion valuation, co-led by Sequoia Capital and Kleiner Perkins. Existing investors Lightspeed Venture Partners, Khosla Ventures, Saga Ventures, and South Park Commons also participated alongside new investor Evantic. Wilson Sonsini Goodrich & Rosati advised Profound on the transaction.
Learn More
Client Highlights
Firm Advises DISA Uranium on Asset Purchase with Premier American Uranium
On September 15, 2026, DISA Uranium, an American company built to recover and produce domestic uranium and remediate the nation's legacy uranium sites, announced it has entered into an asset purchase agreement with Premier American Uranium to acquire a portfolio of uranium projects in Colorado. Wilson Sonsini Goodrich & Rosati advised DISA Uranium on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Superpose on $2.2 Million Seed Financing
On September 15, 2026, Superpose, an AI-powered portrait camera app for iPhone, announced a $2.2 million seed funding round led by Khosla Ventures. Meitu and OVTR VC also participated in the funding round. Superpose uses real-time camera guidance and generative AI to turn a single photo into four enhanced versions of the same moment. Since launching on the iOS App Store in 2026, the app has surpassed twenty thousand installs and generated more than 190,000 superposes. Wilson Sonsini Goodrich & Rosati advised Superpose on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises DoorDash on $300 Million Acquisition of Wonder’s Grubhub Campus Dining Business
On September 15, 2026, DoorDash, a global leader in local commerce, and Wonder, a leading food technology platform, announced that DoorDash will acquire Wonder's Grubhub Campus Dining business for $300 million. Wilson Sonsini Goodrich & Rosati advised DoorDash on the transaction.

Grubhub Campus Dining, formerly known as Tapingo, enables millions of students at more than 450 colleges and universities to order a meal from campus dining facilities and on-campus restaurants using its mobile app or kiosks, pay for the meal with campus dining dollars, and schedule the pickup. Following the close of the transaction, DoorDash intends to continue expanding Grubhub Campus Dining in the U.S., enhance the selection and convenience available to students, and bring Tapingo’s vertically integrated technology stack beyond college campuses to stadiums, hotels, and other similar venues. 

The Wilson Sonsini team that advised DoorDash on the transaction was led by partners Rezwan Pavri, Lang Liu, Sachin Kohli, and Brendan Mahan and associates Ryan Cooper and Jackie Jung. The team also included:
Learn More
Client Highlights
Wilson Sonsini Advises Xapien on $56 Million Series B
On September 11, 2026, Xapien, an AI-native due diligence platform, announced a $56 million Series B investment round led by Spectrum Equity, with continued support from existing investor YFM Equity Partners. Wilson Sonsini Goodrich & Rosati advised Xapien on the transaction.
Learn More
Client Highlights
Wilson Sonsini Secures HKIAC Arbitration Final Award for Clients
On September 8, 2026, the Hong Kong International Arbitration Centre (HKIAC) issued a final award (the Final Award) in a dispute between Leed Education Holding Limited, National Education Holding Limited, and Hyde Education Holding Limited (collectively, the Claimants) and Minsheng Vocational Education Company Limited (the Respondent), a subsidiary of Hong Kong-listed Minsheng Education Group Company Limited (Minsheng Education). Wilson Sonsini Goodrich & Rosati acts for the Claimants in the arbitration.
Learn More
See More Leading Matters
The Life Sciences Report – June 2026

This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.

Read More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.